Best Life Sciences Platforms and Tools Companies in Austria
The 49 best Life Sciences Platforms and Tools companies in Austria in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Ribbon Biolabs.
- Precedence Research
- ResearchAndMarkets.com
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Platforms and Tools companies in Austria
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Ribbon Biolabs Developer of a technology platform for the synthesis of long DNA molecules | $20M | 54 mo ago | Series A | Harold De Vladar Founder and Advisory Board Member | 2017 | — | 30 patents Enzymatic synthesis and assembly of custom nucleic acid polymers. | 3 launchs |
| 2 | Sarcura Developer of cell therapy solutions for multiple therapeutic areas | $10M | 38 mo ago | Seed | Erwin Gorjup Chief Scientific Officer & Co-Founder | 2019 | WordPressMySQLPHP+12 | — | — |
| 3 | Biocrates Developer of targeted metabolic phenotyping solutions | $8M | 82 mo ago | Acquired | — | 2002 | WordPressZohoMySQL+28 | — | — |
| 4 | HeartBeat Developer of stem-cell derived organoid models for cardiac drug discovery | $7M | 33 mo ago | Seed | Michael Krebs Founder & CEO | 2021 | WebflowApple iCloud MailMicrosoft 365+11 | — | — |
| 5 | a:head bio Developer of therapeutics based on human cerebral organoids for brain disorders | $3M | 81 mo ago | Funding Raised | Oliver Szolar CEO | 2018 | WordPressMySQLPHP+12 | — | — |
| 6 | Valanx Biotech Develops tools for protein conjugation | $3M | 5 mo ago | Series A | Georg Altenbacher Co-Founder & CBO | 2017 | WordPressMySQLPHP+12 | 15 patents Bio-orthogonal click chemistry reagents for site-specific protein/peptide modification | — |
| 7 | PhagoMed Company developing alternatives to antibiotics through their expertise in phage therapy | $2M | 85 mo ago | Acquired | Burkhard Wippermann Co-Founder | 2016 | — | — | — |
| 8 | BIA Separations Develops monolithic chromatographic columns based on Convective Interaction Media Technology | $2M | 52 mo ago | Acquired | — | 1998 | WordPressMySQLPHP+23 | 17 patents Sulfated (SO3) chromatography media for virus purification in biopharmaceutical processing | — |
| 9 | IONICON Real-time trace gas analyzers based on PTR-MS technology | $1M | 31 mo ago | Funding Raised | Lukas Mark CEO | 2010 | TYPO3 CMSPHPNginx+3 | — | 1 launch |
| 10 | Evercyte Cell lines, reagents and research services for pharma and cell therapies | $1M | 47 mo ago | Funding Raised | Otto Kanzler CEO & Co-Founder | 2011 | Cart FunctionalityWooCommerceWordPress+20 | 14 patents Targeted extracellular vesicle platforms for precision drug delivery | — |
| 11 | TissueGnostics Provider of instruments and software for digital pathology | $984K | 47 mo ago | Public | — | 2003 | JoomlaPHPGSAP+7 | 16 patents Automated histological image analysis and leukocyte segmentation for diagnostic pathology | — |
| 12 | Cube Dx Provider of cylindrical microarray therapy for sepsis detection and cancer | $786K | 126 mo ago | Funding Raised | Fawaz Linjawi Co-Founder | 2015 | Mono.netMapbox GL JSLeaflet+12 | 3 patents Thermal control for cylindrical reactors and liquid sample analytical instrumentation. | — |
| 13 | Engenes Developer of recombinant proteins | $773K | 103 mo ago | Funding Raised | Jens Pontiller Co-Founder | 2014 | WixSentryBootstrap+15 | — | 2 partnerships |
| 14 | KiloBaser Developer of DNA and RNA synthesizer for research applications | $625K | 61 mo ago | Seed | Bernhard Tittelbach CoFounder / CTO | 2014 | Cart FunctionalityNode.jsReact+12 | 8 patents Microfluidic lab‑on‑chip valves for automated oligonucleotide synthesis | — |
| 15 | Saphium Compostable 3D printer filaments | $253K | — | Seed | Christof Winkler-Hermaden Chief Executive Officer - Chief Strategy Officer | 2015 | — | — | — |
| 16 | The Antibody Lab Company developing immunoassays and preclinical biologics through their proprietary antibody engineering and… | $110K | 129 mo ago | Funding Raised | Gottfried Himmler co-founder | 2014 | — | 7 patents Lectin-based microbial contamination assays and cardiac NT‑proBNP biomarker diagnostics | — |
Top 12 Life Sciences Platforms and Tools companies in Austria
#1
Series A · Graz, Styria · founded 2017 · 11 employees$2.7Mraised▾
VALANX is a biotech company that develops a site-specific protein conjugation platform to enable fast antibody-drug conjugates development as well as peptide conjugates and oriented immobilization for biosensors. They have patented reactive amino acid at defined sites and the site is encoded on the DNA level and is freely selectable.
- Mar 2026Series A$3.5M
- Nov 2023Series A$2.5M
- 2020Seed—
- Seed$253.4K
#2
Seed · Sankt Andra Wordern, Niederosterreich · founded 2019 · 25 employees$10.2Mraised▾
Developer of cell therapy solutions for multiple therapeutic areas. The company is focused on developing new and innovative manufacturing systems for personalized cell therapies. They use silicon and microfluidic structures to enable processing on a cellular level, and functional modules allow for individual process designs and conceptional flexibility.
- Jun 2023Grant (prize money)$80.6K
- Nov 2022Seed$7.3M
- Nov 2020Grant (prize money)—
- Nov 2020Seed$3M
#3
Seed · Vienna, Vienna · founded 2021 · 14 employees$6.6Mraised▾
Developer of stem-cell-derived organoid models for cardiac drug discovery. The company has a high-throughput 3D screening platform based on cardiac organoids for cardiovascular drug discovery.
- Nov 2023Seed$4.8M
- May 2021Seed$1.8M
#4
Series A · Vienna, Vienna · founded 2017 · 38 employees$20.1Mraised▾
Developer of a technology platform for the synthesis of long DNA molecules. The company uses genetic solutions by the high-throughput synthesis of DNA. The company is focusing on libraries of DNAs of lengths of up to thousands of base pairs. The company is building genomes, high-throughput libraries, along with providing new products based on DNA, storing data, computing with DNA, and building DNA-based nanotechnological devices.
- Jan 2022Series A$20.1M
- May 2020Grant (prize money)$55.5K
- Dec 2019Grant (prize money)$55.1K
- Mar 2019Seed—
#5
Funding Raised · Innsbruck, Tyrol · founded 2010$1.3Mraised▾
Ionicon is a life science precision instruments company that specializes in the development and manufacture of real-time gas analyzers centered around its core technologies - Proton Transfer Reaction - Mass Spectrometry (PTR-MS), Selective Reagent Ionization Mass Spectrometry (SRI-MS), Ion guide multi-pole technology and Ion funnel technology. The company manufactures PTR-MS systems and bespoke solutions for online VOC monitoring and real-time trace gas detection for environmental research, biotechnology research, food and flavor research, automotive and petrochemical research, and medical applications, among others.
- Jan 2024Grant (prize money)$121.6K
- Sep 2022Grant (prize money)$268.8K
- Sep 2017Grant (prize money)$303.6K
- Jan 2017Grant (prize money)$271K
#6
Acquired · Innsbruck, Tyrol · founded 2002 · 63 employees$7.9Mraised▾
Biocartes Life Sciences develops kits for targeted metabolic phenotyping solutions. The company has two product lines: Research and Diagnostic. The Research product line provides five sets of reagents and kits (AbsoluteIDQ) to analyze and quantify 188 metabolites from five different metabolite classes, including bile salts and steroids. The Diagnostic product line consists of the SteroIDQ Kit, a CE-marked in vitro diagnostic test for simultaneous quantitative analysis of 16 steroid hormones. It claims to use a proprietary software solution is to manage the entire analysis workflow, while enhancing the standardization and harmonization of project data processing.
- Sep 2019Series B—
- Feb 2018Grant (prize money)$197.4K
- Jan 2018Series B—
- Jan 2018Grant (prize money)$190.3K
#7
Acquired · Villach, Carinthia · founded 1998 · 2 employees$1.7Mraised▾
BIA Separations manufactures and sells laboratory and industrial proprietary short monolithic chromatographic columns based on CIM (Convective Interaction Media) Technology. CIM Monolithic Columns are suitable for purification of large biomolecules such as viruses (viral vectors and vaccines), DNA (plasmid DNA) and larger proteins (Immunoglobulins G and M, pegylated proteins). CIM Monolithic Columns exhibit unrivaled characteristics in terms of operational flow rates, binding capacity and separation resolution for large biomolecules. Products are used in research, laboratory, pilot and industrial production stages.
#8
Funding Raised · Vienna, Vienna · founded 2011 · 7 employees$1Mraised▾
Evercyte is a cell biology company focused on developing primary cells and patient-specific iPSC cell lines for use in drug discovery and therapeutics development. The company develops immortalized human somatic cells (endothelial cells, renal cells, keratinocytes, melanocytes, fibroblasts, etc), adult stem cells and iPSCs, 3D cultured human skin panels, etc. for in vitro assay development, biologics/protein production, and for the development of cell-based therapies. The company also develops customer tailored cell lines and cell-based assays.
- Sep 2022Grant (prize money)$268.8K
- Nov 2021Grant (prize money)$495.9K
- Jan 2017Grant (prize money)$269.4K
#9
Public · Vienna, Vienna · founded 2003$984.3Kraised▾
Provider of instruments and software for digital pathology. The company's products inlcude tissue cytometers, immune status of organs, Molecular single-cell profiling, TissueQuest for fluorescence image analysis, HistoQuest for brightfield image analysis, and StrataQuest for multicellular contextual tissue analysis.
- Sep 2022Grant (prize money)$403.2K
- Jan 2019Grant (prize money)$302.8K
- Mar 2016Grant (prize money)$278.3K
#10
Funding Raised · Vienna, Vienna · founded 2018 · 15 employees$2.8Mraised▾
a:head bio is developing therapeutic agents for treating brain disorders by in vitro studies using human brain disorders. The company is developing 3D tissue cultures (mini-brains) from human stem cells through in vitro experiments to understand the brain's developmental processes. The tissue cultures are a high throughput phenotyping platform used for the development and testing of therapeutic agents designed for treating brain disorders.
- Oct 2019Grant (prize money)$2.8M
#11
Acquired · Vienna, Vienna · founded 2016 · 14 employees$1.7Mraised▾
PhagoMed is a developing a phage drug development platform through which they are advancing a portfolio of candidates currently at the preclinical stage. The company claims that phage therapy is a better alternative to antibiotics due to the issue of resistance, their insufficient effectiveness against biofilms and also due to their side effects. In exceptional and severe cases the company is exploring experimental treatment options as per the Helsinki protocol for wound and periprosthetic infections. The company is looking for partners to establish preclinical proof of their technology.
- Jul 2019Seed$1.7M
- 2018Grant (prize money)—
#12
Seed · Graz, Styria · founded 2014 · 16 employees$625Kraised▾
Developer of DNA and RNA synthesizer for research applications. It offers KiloBaser a microfluidic chip and cartridge based DNA and RNA synthesizer to produce custom DNA and RNA on demand. It also, offers Kilobaser MultiRack to provide laboratories with high demand for DNA probes with procurement option.
- 2021Seed$125K
- 2014Seed$500K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth flat
How research on Bioinformatics is moving in Austria
A read on the academic research around Bioinformatics — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 415 Austria-affiliated papers.
- Medical University of Vienna56
- University of Vienna48
- Innsbruck Medical University46
- Medical University of Graz36
- Austrian Academy of Sciences27
- Genome2→17
- Cancer1→8
- Metagenomics2→8
- Sequence (biology)1→4
- Gene3→6
- Disease11
- Computational biology6
- Immune system6
- Genetics5
- Genome5
- Disease1→8
- Microbiome1→4
- Genomics1→4
Where bioinformatics is researched across Austria
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.